FineMark National Bank & Trust - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 80 filers reported holding REVANCE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.

Quarter-by-quarter ownership
FineMark National Bank & Trust ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$35,000
-74.6%
1,700
-80.0%
0.00%
-80.0%
Q3 2016$138,000
+885.7%
8,500
+750.0%
0.02%
+650.0%
Q2 2016$14,000
-17.6%
1,0000.0%0.00%0.0%
Q1 2016$17,000
-50.0%
1,0000.0%0.00%
-50.0%
Q4 2015$34,000
-43.3%
1,000
-50.0%
0.00%
-50.0%
Q3 2015$60,000
-6.2%
2,0000.0%0.01%0.0%
Q2 2015$64,000
+56.1%
2,0000.0%0.01%
+33.3%
Q1 2015$41,000
+20.6%
2,0000.0%0.01%
+20.0%
Q4 2014$34,000
-12.8%
2,0000.0%0.01%
-16.7%
Q3 2014$39,0002,0000.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
NQ HCIF GP, Ltd. 3,096,650$52,457,000100.00%
Essex Woodlands Management, Inc. 4,592,047$77,789,00024.28%
Rhenman & Partners Asset Management AB 126,574$2,144,0000.62%
Polar Capital LLP 1,107,272$18,756,0000.37%
ArrowMark Colorado Holdings LLC 787,923$13,347,0000.34%
Lombard Odier Asset Management (USA) Corp 250,605$4,245,0000.29%
Visium Asset Management, LP 1,000,000$16,940,0000.24%
C Partners Holding GmbH 24,000$407,0000.13%
NOTTINGHAM ADVISORS, INC. 23,018$390,0000.10%
WALL STREET ASSOCIATES 57,330$971,0000.09%
View complete list of REVANCE THERAPEUTICS INC shareholders